tiletamine hydrochloride has been researched along with interleukin-8 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bando, H; Matsumoto, G; Muta, M; Nakamura, T; Namekawa, J; Tohyama, K; Toi, M; Umezawa, K | 1 |
Flynn, BL; Masters, KS | 1 |
Caggia, S; Cardile, V; Frasca, G; Libra, M; Malaponte, G; Panico, A; Umezawa, K | 1 |
Bevelacqua, Y; Caggia, S; Cardile, V; Coco, M; Frasca, G; Libra, M; Malaponte, G; Mazzarino, MC; Stivala, F; Umezawa, K | 1 |
Fukai, M; Funakoshi, T; Goto, R; Ichihara, S; Ichikawa, N; Katsurada, T; Kobayashi, N; Oura, T; Ozaki, M; Suzuki, T; Todo, S; Umezawa, K; Yamashita, K | 1 |
Aiura, K; Itano, O; Kitagawa, Y; Matsuda, S; Suzuki, K; Takeuchi, O; Umezawa, K | 1 |
Aoki, D; Fujii, T; Iwata, T; Kawakami, Y; Kawamura, N; Kobayashi, A; Nishio, H; Park, J; Sugiyama, J; Sumimoto, H; Susumu, N; Umezawa, K; Yaguchi, T | 1 |
Fukuda, K; Fukushima, A; Hirakata, A; Inokawa, S; Keino, H; Okada, AA; Sato, Y; Umezawa, K; Watanabe, T | 1 |
8 other study(ies) available for tiletamine hydrochloride and interleukin-8
Article | Year |
---|---|
Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cyclohexanones; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Interleukin-6; Interleukin-8; Lymphotoxin-alpha; Male; Mice; Mice, Inbred BALB C; Mice, SCID; NF-kappa B; Phosphorylation; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2005 |
An efficient synthesis of (+/-)-frondosin B using a Stille-Heck reaction sequence.
Topics: Cyclohexanones; Heterocyclic Compounds, 4 or More Rings; Interleukin-8; Mesylates; Stereoisomerism | 2010 |
Dehydroxymethylepoxyquinomicin inhibits expression and production of inflammatory mediators in interleukin-1beta-induced human chondrocytes.
Topics: Benzamides; Cartilage, Articular; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chondrocytes; Cyclohexanones; Cyclooxygenase 2; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-8; Nitrates; Nitric Oxide Synthase Type II | 2010 |
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Line; Chemokine CCL2; Chemokine CCL5; Cyclohexanones; Histamine; Humans; Hydrocortisone; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-8; Keratinocytes; NF-kappa B | 2010 |
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Topics: Animals; Benzamides; CD4-Positive T-Lymphocytes; Chemokine CCL2; Colitis; Cyclohexanones; Cytokines; Dextran Sulfate; HT29 Cells; Humans; Interleukin-12 Subunit p40; Interleukin-17; Interleukin-1beta; Interleukin-6; Interleukin-8; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; RNA, Messenger; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2012 |
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Movement; Cell Proliferation; Cyclohexanones; Deoxycytidine; Disease Models, Animal; Fluorescent Antibody Technique; Gemcitabine; Humans; Immunoenzyme Techniques; Interleukin-8; Liver Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2013 |
Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.
Topics: Adoptive Transfer; Animals; Arginase; Benzamides; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Culture Media, Conditioned; Cyclohexanones; Dendritic Cells; Female; Humans; Immune Tolerance; Interleukin-6; Interleukin-8; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Signal Transduction; Transcription Factor RelA; Transplantation, Heterologous | 2014 |
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts.
Topics: Benzamides; Cell Proliferation; Cell Survival; Cells, Cultured; Chemokine CCL2; Corneal Keratocytes; Cyclohexanones; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-8; NF-kappa B; Transcription Factor RelA | 2015 |